全球细胞活力测定市场规模、份额和成长分析：按产品、按应用、按最终用户、按地区 - 产业预测 (2024-2031)

2022 年，全球细胞活力检测市场规模为 13.8 亿美元，从 2023 年的 15.2 亿美元成长到 2031 年的 32.4 亿美元，预计在预测期内（2024 年~2031 年）将以年复合成长率为9.94 %。

由于药物开发需求的增加以及製药和生物技术领域的进步，全球细胞活力测定（CVA）市场正在经历显着增长。细胞活力是细胞健康的重要指标，受到化学和物理因素（包括毒性因素）的影响。 CVA 是评估细胞对药物和病原体反应的重要工具，使其成为早期药物发现的重要组成部分。这些测定有助于评估化合物的效率、毒性和安全性，这对于药物开发至关重要。随着製药业关注新疗法和药物安全性，对细胞活力测定的需求预计将增长，并进一步扩大其在医学研究和药物测试中的应用。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 次要/一级资讯来源
• 市场规模估算
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制因素和挑战
• 波特的分析和影响
  • 竞争公司之间的敌对关係
  • 替代品的威胁
  • 买方议价能力
  • 新进入者的威胁
  • 供应商的议价能力

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 技术进步
• 监管环境
• 专利分析
• 价值链分析
• 案例研究分析
• 客户和购买标准分析
• PESTEL分析
• 宏观经济指标
• 市场吸引力指数

细胞活力测定市场规模：依产品，复合年增长率（2024-2031）

• 市场概况
• 消耗品
• 装置

细胞活力测定市场规模：依应用划分，复合年增长率（2024-2031）

• 市场概况
• 基础研究
• 干细胞研究
• 药物发现与开发
• 临床/诊断用途
• 其他用途

细胞活力测定市场规模：依最终用户划分，复合年增长率（2024-2031）

• 市场概况
• 学术研究所
• 製药和生物技术公司
• 医院/诊断实验室
• 其他最终用户

细胞活力测定市场规模及复合年增长率（2024-2031）

• 北美（产品、应用、最终用户）
  • 美国
  • 加拿大
• 欧洲（产品、应用程式、最终用户）
  • 英国
  • 德国
  • 西班牙
  • 法国
  • 义大利
  • 其他欧洲国家
• 亚太地区（产品、应用、最终用户）
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲（产品、应用、最终用户）
  • 巴西
  • 其他拉丁美洲
• 中东/非洲（产品、应用程式、最终用户）
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• F. Hoffmann-La Roche AG
• Danaher Corporation
• Lonza Group AG
• Promega Corporation
• Charles River Laboratories International, Inc.
• Menarini Silicon Biosystems, Inc.
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Macrogen Inc
• DiscoverX Corporation
• Corning Inc.
• Merck KGaA
• Thermo Fisher Scientific Inc.
• Perkinelmer, Inc.
• Biognosys
• Cell Signaling Technology, Inc.
• Lebermuth, Inc.
• Eurofins DiscoverX Products
• GE Healthcare
• Beckman Coulter,Inc.

结论和建议

Global Cell Viability Assays Market size was valued at USD 1.38 Billion in 2022 and is poised to grow from USD 1.52 Billion in 2023 to USD 3.24 Billion by 2031, growing at a CAGR of 9.94% in the forecast period (2024-2031).

The global Cell Viability Assays (CVA) market is witnessing significant growth, driven by the increasing demand for drug development and advancements in the pharmaceutical and biotechnology sectors. Cell viability, a critical indicator of cell health, is affected by chemical or physical agents, including toxicity factors. CVAs are essential tools for assessing cellular responses to drugs or pathogens, making them indispensable in early-stage drug discovery. These assays help evaluate compound efficiency, toxicity, and safety profiles, which are vital for drug development. As the pharmaceutical industry focuses on novel therapies and drug safety, the demand for cell viability assays is expected to grow, further expanding their applications in medical research and drug testing.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cell Viability Assays market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cell Viability Assays Market Segmental Analysis

Global Cell Viability Assays Market is segmented by Product, application, end user and region. Based on Product, the market is segmented into Consumables, Instruments. Based on application, the market is segmented into Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications, Other Applications. Based on end user, the market is segmented into Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospital and Diagnostic Laboratories, Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Cell Viability Assays Market

The continuous investment in research and development by manufacturers to introduce new drugs for treating various conditions is a significant driver in the global Cell Viability Assays market. The pharmaceutical and biotechnology industries heavily rely on cell viability assays for critical processes such as drug discovery, toxicity testing, and evaluating drug efficiency. This ongoing development and innovation within these sectors are driving the growing demand for advanced assays, as they play a crucial role in ensuring the safety and efficacy of new therapeutics. As these industries expand, the need for more precise and reliable assays continues to rise, further fueling market growth.

Restraints in the Global Cell Viability Assays Market

The global Cell Viability Assays market faces significant restraints due to strict regulations on the use of reagents, which impede market growth. Additionally, the high cost of necessary instruments further limits expansion. Certain cell-based assays require specific reagents, such as antibodies, growth factors, cytokines, or fluorescent dyes, to detect and measure cellular responses. These specialized reagents often face limitations due to intellectual property rights, licensing agreements, or limited commercial availability, further hindering market development. As a result, the combination of regulatory restrictions and high costs of both reagents and instruments presents a substantial challenge to the growth of the cell viability assay market.

Market Trends of the Global Cell Viability Assays Market

Continuous innovation in the characteristics of cell viability assays is driving the growth of the global market. Manufacturers are increasingly integrating these assays with emerging technologies such as artificial intelligence (AI) and machine learning, significantly enhancing data analysis, interpretation, and overall assay performance. These advancements not only improve the accuracy and efficiency of cell viability testing but also contribute to more reliable and faster results, which is fostering the growth of the market. As these technologies evolve, the demand for advanced, high-performance cell viability assays continues to rise, further accelerating market expansion.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Value Chain Analysis
• Case Study Analysis
• Customer & Buying Criteria Analysis
• PESTEL Analysis
• Macro-Economic Indicators
• Market Attractiveness Index

Global Cell Viability Assays Market Size byProduct & CAGR (2024-2031)

• Market Overview
• Consumables
• Instruments

Global Cell Viability Assays Market Size byApplication & CAGR (2024-2031)

• Market Overview
• Basic Research
• Stem Cell Research
• Drug Discovery & Development
• Clinical & Diagnostic Applications
• Other Applications

Global Cell Viability Assays Market Size by End User & CAGR (2024-2031)

• Market Overview
• Academic and Research Institutes
• Pharmaceutical and Biotechnology Companies
• Hospital and Diagnostic Laboratories
• Other End Users

Global Cell Viability Assays Market Size & CAGR (2024-2031)

• North America, (Product, Application, End User)
  • US
  • Canada
• Europe, (Product, Application, End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Product, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Product, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (Product, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• F. Hoffmann-La Roche AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories International, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Menarini Silicon Biosystems, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macrogen Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiscoverX Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corning Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Perkinelmer, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biognosys
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Signaling Technology, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lebermuth, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins DiscoverX Products
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter,Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation